ASTH vs. LIF, LYFT, AMTM, MARA, WPP, QBTS, ETSY, STNE, FTDR, and WSC
Should you be buying Astrana Health stock or one of its competitors? The main competitors of Astrana Health include Life360 (LIF), Lyft (LYFT), Amentum (AMTM), Marathon Digital (MARA), WPP (WPP), D-Wave Quantum (QBTS), Etsy (ETSY), StoneCo (STNE), Frontdoor (FTDR), and WillScot (WSC). These companies are all part of the "business services" industry.
Astrana Health vs. Its Competitors
Astrana Health (NASDAQ:ASTH) and Life360 (NASDAQ:LIF) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations.
52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 20.0% of Life360 shares are owned by institutional investors. 8.5% of Astrana Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
In the previous week, Life360 had 4 more articles in the media than Astrana Health. MarketBeat recorded 9 mentions for Life360 and 5 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.64 beat Life360's score of 0.50 indicating that Astrana Health is being referred to more favorably in the media.
Astrana Health currently has a consensus target price of $53.29, suggesting a potential upside of 73.48%. Life360 has a consensus target price of $86.43, suggesting a potential downside of 1.83%. Given Astrana Health's higher probable upside, equities analysts clearly believe Astrana Health is more favorable than Life360.
Astrana Health has higher revenue and earnings than Life360. Astrana Health is trading at a lower price-to-earnings ratio than Life360, indicating that it is currently the more affordable of the two stocks.
Life360 has a net margin of 6.45% compared to Astrana Health's net margin of 1.04%. Life360's return on equity of 7.65% beat Astrana Health's return on equity.
Astrana Health has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Comparatively, Life360 has a beta of 3.5, suggesting that its share price is 250% more volatile than the S&P 500.
Summary
Life360 beats Astrana Health on 9 of the 16 factors compared between the two stocks.
Get Astrana Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Astrana Health Competitors List
Related Companies and Tools
This page (NASDAQ:ASTH) was last updated on 9/4/2025 by MarketBeat.com Staff
